{"id":224,"date":"2017-05-05T10:55:53","date_gmt":"2017-05-05T10:55:53","guid":{"rendered":"http:\/\/www.filha.fi\/content_page\/support-to-five-high-priority-member-states-in-prevention-and-control-of-multidrug-resistant-tuberculosis\/"},"modified":"2021-03-30T14:29:31","modified_gmt":"2021-03-30T11:29:31","slug":"support-to-five-high-priority-member-states-in-prevention-and-control-of-multidrug-resistant-tuberculosis","status":"publish","type":"page","link":"https:\/\/www.filha.fi\/en\/hankkeet\/paattyneet\/support-to-five-high-priority-member-states-in-prevention-and-control-of-multidrug-resistant-tuberculosis\/","title":{"rendered":"Support to five high priority Member States in prevention and control of (Multidrug Resistant) Tuberculosis"},"content":{"rendered":"<table border=\"1\" cellspacing=\"0\" cellpadding=\"0\">\n<tbody>\n<tr>\n<td>Duration<\/td>\n<td>2016\u20132018<\/td>\n<\/tr>\n<tr>\n<td>Implementation<\/td>\n<td>Consortium of Filha and TBC Consult (Nonna Turusbekova)<\/td>\n<\/tr>\n<tr>\n<td>Contracting authority<\/td>\n<td>European Centre for Disease Prevention and Control ECDC<\/td>\n<\/tr>\n<tr>\n<td>Short description<\/td>\n<td>The project aims to support Bulgaria, Estonia, Latvia, Lithuania, and Romania in prevention and control of multidrug-resistant tuberculosis.<\/td>\n<\/tr>\n<tr>\n<td>Contact person<\/td>\n<td>Mikko Vauhkonen, +358 44 5442203<br \/>\n<a href=\"mailto:mikko.vauhkonen@filha.fi\">mikko.vauhkonen@filha.fi<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>Activities in 2016:<\/h2>\n<ul>\n<li>Training in Tallinn, Estonia 27.\u201329.9.2016 on latent tuberculosis infection (LTBI) management, 30 participants<\/li>\n<li>Exchange visit to Helsinki and Turku, Finland 10.\u201314.10.2016 on tuberculosis contact tracing, 20 participants<\/li>\n<li>Concept paper for Romania on a) sustainability of integrated community support services for (MDR) TB treatment and b) training outline for community outreach workers engagement in (MDR) TB treatment adherence<\/li>\n<\/ul>\n<h2>Activities in 2017:<\/h2>\n<ul>\n<li>Exchange visit to Helsinki, Finland 9.-12.5.2017 with topic &#8220;From hospital to ambulatory care&#8221;, 20 participants<\/li>\n<li>Training in Sofia, Bulgaria 19.\u201321.10.2017 on prevention and control of TB among vulnerable and hard-to-reach groups and migrants, 25 participants<\/li>\n<li>Consultancy for Latvia to develop a national guideline for LTBI preventive treatment for HIV patients and a surveillance registry for LTBI cases and TB contacts<\/li>\n<\/ul>\n<h2>Activities in 2018<\/h2>\n<ul>\n<li>Exchange visit to Groningen, the Netherlands 23.\u201327.4.2018 with topic &#8220;Tuberculosis infection control: Assessment and implementation of infection control procedures and measures&#8221;, 20 participants<\/li>\n<li>Training in Vilnius, Lithuania 1.\u20133.10.2018 on communication about tuberculosis to general public and use of social media, advocacy and communication to local government and policy makers, 20 participants<\/li>\n<li>Consultancy for Lithuania to develop a national guideline on integrated services with a focus on case management of MDR TB cases, TB\/HIV co-infected cases and cases belonging to vulnerable populations<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Duration 2016\u20132018 Implementation Consortium of Filha and TBC Consult (Nonna Turusbekova) Contracting authority European Centre for Disease Prevention and Control ECDC Short description The project aims to support Bulgaria, Estonia, &#8230; <a title=\"Support to five high priority Member States in prevention and control of (Multidrug Resistant) Tuberculosis\" class=\"read-more\" href=\"https:\/\/www.filha.fi\/en\/hankkeet\/paattyneet\/support-to-five-high-priority-member-states-in-prevention-and-control-of-multidrug-resistant-tuberculosis\/\" aria-label=\"Read more about Support to five high priority Member States in prevention and control of (Multidrug Resistant) Tuberculosis\">Read more<\/a><\/p>\n","protected":false},"author":4,"featured_media":0,"parent":87,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"categories":[3],"class_list":["post-224","page","type-page","status-publish","category-tuberkuloosi"],"translation":{"provider":"WPGlobus","version":"3.0.2","language":"en","enabled_languages":["fi","en"],"languages":{"fi":{"title":true,"content":true,"excerpt":false},"en":{"title":false,"content":false,"excerpt":false}}},"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Support to five high priority Member States in prevention and control of (Multidrug Resistant) Tuberculosis - Filha<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.filha.fi\/hankkeet\/paattyneet\/support-to-five-high-priority-member-states-in-prevention-and-control-of-multidrug-resistant-tuberculosis\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Support to five high priority Member States in prevention and control of (Multidrug Resistant) Tuberculosis - Filha\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.filha.fi\/hankkeet\/paattyneet\/support-to-five-high-priority-member-states-in-prevention-and-control-of-multidrug-resistant-tuberculosis\/\" \/>\n<meta property=\"og:site_name\" content=\"Filha\" \/>\n<meta property=\"article:modified_time\" content=\"2021-03-30T11:29:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.filha.fi\/wp-content\/uploads\/2019\/04\/Filha-logo.png\" \/>\n\t<meta property=\"og:image:width\" content=\"960\" \/>\n\t<meta property=\"og:image:height\" content=\"1230\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.filha.fi\\\/hankkeet\\\/paattyneet\\\/support-to-five-high-priority-member-states-in-prevention-and-control-of-multidrug-resistant-tuberculosis\\\/\",\"url\":\"https:\\\/\\\/www.filha.fi\\\/hankkeet\\\/paattyneet\\\/support-to-five-high-priority-member-states-in-prevention-and-control-of-multidrug-resistant-tuberculosis\\\/\",\"name\":\"Support to five high priority Member States in prevention and control of (Multidrug Resistant) Tuberculosis - Filha\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.filha.fi\\\/#website\"},\"datePublished\":\"2017-05-05T10:55:53+00:00\",\"dateModified\":\"2021-03-30T11:29:31+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.filha.fi\\\/hankkeet\\\/paattyneet\\\/support-to-five-high-priority-member-states-in-prevention-and-control-of-multidrug-resistant-tuberculosis\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.filha.fi\\\/hankkeet\\\/paattyneet\\\/support-to-five-high-priority-member-states-in-prevention-and-control-of-multidrug-resistant-tuberculosis\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.filha.fi\\\/hankkeet\\\/paattyneet\\\/support-to-five-high-priority-member-states-in-prevention-and-control-of-multidrug-resistant-tuberculosis\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.filha.fi\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Hankkeet\",\"item\":\"https:\\\/\\\/www.filha.fi\\\/hankkeet\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"P\u00e4\u00e4ttyneet hankkeet\",\"item\":\"https:\\\/\\\/www.filha.fi\\\/hankkeet\\\/paattyneet\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Support to five high priority Member States in prevention and control of (Multidrug Resistant) Tuberculosis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.filha.fi\\\/#website\",\"url\":\"https:\\\/\\\/www.filha.fi\\\/\",\"name\":\"Filha\",\"description\":\"Expertise in lung health\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.filha.fi\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.filha.fi\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.filha.fi\\\/#organization\",\"name\":\"Filha ry\",\"url\":\"https:\\\/\\\/www.filha.fi\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.filha.fi\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.filha.fi\\\/wp-content\\\/uploads\\\/2019\\\/04\\\/Filha-logo.png\",\"contentUrl\":\"https:\\\/\\\/www.filha.fi\\\/wp-content\\\/uploads\\\/2019\\\/04\\\/Filha-logo.png\",\"width\":960,\"height\":1230,\"caption\":\"Filha ry\"},\"image\":{\"@id\":\"https:\\\/\\\/www.filha.fi\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Support to five high priority Member States in prevention and control of (Multidrug Resistant) Tuberculosis - Filha","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.filha.fi\/hankkeet\/paattyneet\/support-to-five-high-priority-member-states-in-prevention-and-control-of-multidrug-resistant-tuberculosis\/","og_locale":"en_US","og_type":"article","og_title":"Support to five high priority Member States in prevention and control of (Multidrug Resistant) Tuberculosis - Filha","og_url":"https:\/\/www.filha.fi\/hankkeet\/paattyneet\/support-to-five-high-priority-member-states-in-prevention-and-control-of-multidrug-resistant-tuberculosis\/","og_site_name":"Filha","article_modified_time":"2021-03-30T11:29:31+00:00","og_image":[{"width":960,"height":1230,"url":"https:\/\/www.filha.fi\/wp-content\/uploads\/2019\/04\/Filha-logo.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.filha.fi\/hankkeet\/paattyneet\/support-to-five-high-priority-member-states-in-prevention-and-control-of-multidrug-resistant-tuberculosis\/","url":"https:\/\/www.filha.fi\/hankkeet\/paattyneet\/support-to-five-high-priority-member-states-in-prevention-and-control-of-multidrug-resistant-tuberculosis\/","name":"Support to five high priority Member States in prevention and control of (Multidrug Resistant) Tuberculosis - Filha","isPartOf":{"@id":"https:\/\/www.filha.fi\/#website"},"datePublished":"2017-05-05T10:55:53+00:00","dateModified":"2021-03-30T11:29:31+00:00","breadcrumb":{"@id":"https:\/\/www.filha.fi\/hankkeet\/paattyneet\/support-to-five-high-priority-member-states-in-prevention-and-control-of-multidrug-resistant-tuberculosis\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.filha.fi\/hankkeet\/paattyneet\/support-to-five-high-priority-member-states-in-prevention-and-control-of-multidrug-resistant-tuberculosis\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.filha.fi\/hankkeet\/paattyneet\/support-to-five-high-priority-member-states-in-prevention-and-control-of-multidrug-resistant-tuberculosis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.filha.fi\/"},{"@type":"ListItem","position":2,"name":"Hankkeet","item":"https:\/\/www.filha.fi\/hankkeet\/"},{"@type":"ListItem","position":3,"name":"P\u00e4\u00e4ttyneet hankkeet","item":"https:\/\/www.filha.fi\/hankkeet\/paattyneet\/"},{"@type":"ListItem","position":4,"name":"Support to five high priority Member States in prevention and control of (Multidrug Resistant) Tuberculosis"}]},{"@type":"WebSite","@id":"https:\/\/www.filha.fi\/#website","url":"https:\/\/www.filha.fi\/","name":"Filha","description":"Expertise in lung health","publisher":{"@id":"https:\/\/www.filha.fi\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.filha.fi\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.filha.fi\/#organization","name":"Filha ry","url":"https:\/\/www.filha.fi\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.filha.fi\/#\/schema\/logo\/image\/","url":"https:\/\/www.filha.fi\/wp-content\/uploads\/2019\/04\/Filha-logo.png","contentUrl":"https:\/\/www.filha.fi\/wp-content\/uploads\/2019\/04\/Filha-logo.png","width":960,"height":1230,"caption":"Filha ry"},"image":{"@id":"https:\/\/www.filha.fi\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.filha.fi\/en\/wp-json\/wp\/v2\/pages\/224","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.filha.fi\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.filha.fi\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.filha.fi\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.filha.fi\/en\/wp-json\/wp\/v2\/comments?post=224"}],"version-history":[{"count":0,"href":"https:\/\/www.filha.fi\/en\/wp-json\/wp\/v2\/pages\/224\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/www.filha.fi\/en\/wp-json\/wp\/v2\/pages\/87"}],"wp:attachment":[{"href":"https:\/\/www.filha.fi\/en\/wp-json\/wp\/v2\/media?parent=224"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.filha.fi\/en\/wp-json\/wp\/v2\/categories?post=224"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}